U.S. pharmaceutical companies may source Etomidate API from India for laboratory evaluation, formulation development or commercial drug manufacturing. Each supply stage requires a different combination of material quantities, quality records, regulatory information and shipping documents.
Velcare Pharma supplies Etomidate API from India against buyer-defined specifications and commercial requirements. This article explains the available supply stages, documents needed for U.S. importation, sample-request process and factors used to calculate lead time and delivery. The confirmed offer depends on the required grade, quantity, available batch status, pack configuration and intended use.
Etomidate API Supply Options for U.S. Buyers
A U.S. buyer may initially require a small quantity for analytical evaluation, a larger development quantity for formulation work or a commercial order for routine manufacturing. These quantities should be treated as separate procurement stages because they may involve different packaging, documentation and release requirements.
| Supply detail | Information |
| Product | Etomidate API |
| CAS number | 33125-97-2 |
| Available grade | Confirmed against the current pharmacopoeial or customer-specific specification |
| Supply stage | Evaluation sample, development quantity or commercial order |
| Available quantity | Confirmed against released inventory or the production schedule |
| Pack size | Confirmed from the available sample and commercial configurations |
| Retest period | Stated for the batch proposed for supply |
| Source | Original manufacturer, manufacturing site and Velcare’s supply role identified in the applicable documents |
The Etomidate API product page provides indicative product information. The current quotation, specification, Certificate of Analysis and batch documents establish what is being offered for a particular inquiry.
Documents for Supplying Etomidate API to the USA
The document package must support three separate decisions: whether the manufacturing source is acceptable, whether the material meets the required specification and whether the shipment can be entered into the United States under its declared use.
| Document category | Main records |
| Manufacturer qualification | Original-manufacturer details, manufacturing-site address, manufacturing licence and applicable GMP evidence |
| Product quality | Current specification, representative COAs, analytical information, impurity data, stability summary and packaging specification |
| U.S. regulatory support | FDA establishment registration, Etomidate drug listing, Type II DMF and Letter of Authorization where applicable |
| Sample shipment | Sample COA, specification, SDS, invoice, packing list, label and air waybill |
| Commercial shipment | Batch-specific COA, commercial invoice, packing list, transport document, applicable origin record and batch labels |
| FDA entry data | Manufacturer, importer, product code, intended-use code and applicable REG, DLS, IND or drug-application information |
The required FDA entry information changes according to how the imported material will be used. The FDA’s ACE guidance for human drugs identifies the following relevant scenarios:
- IUC 180.017: A chemical imported exclusively for laboratory testing, with no human or animal use. No specific Affirmation of Compliance is listed for this scenario.
- IUC 180.009: A chemical imported for pharmaceutical research and development subject to an Investigational New Drug application. The IND number is mandatory.
- IUC 150.007: An API or bulk drug substance imported for processing into a pharmaceutical product. The drug establishment registration number—REG—and drug listing number—DLS—are mandatory, while the drug application number is conditional.
The documents required at each qualification stage are discussed in more detail in the guides on documents to request from an Etomidate API supplier and regulatory documents for Etomidate API sourcing.
Requesting and Evaluating an Etomidate API Sample
A sample request should identify the intended use, required grade or specification, quantity, planned testing and delivery address. The buyer should also tell the supplier whether the material will be used only for laboratory analysis or in work connected with an IND or another pharmaceutical development program. This allows the sample description and FDA intended-use declaration to reflect its actual purpose.
FDA does not prescribe a universal sample quantity for Etomidate API evaluation. The quantity should be calculated from the material needed for:
- Identity, assay and related-substances testing
- Residual-solvent or other additional analysis
- Repeat or confirmatory testing
- Analytical-method transfer
- Formulation or process-development work
- Retention as a reference sample
The supplier should confirm whether the sample represents the proposed commercial manufacturing site, process and specification. If it was produced at laboratory or pilot scale, that difference should be disclosed because its impurity profile and physical characteristics may not fully represent routine commercial material.
The buyer then evaluates identity, assay, specified and unspecified impurities and any additional attributes required by its product or process. The purpose is not only to determine whether the sample passes its specification, but also to establish whether the source is suitable for further qualification. The complete evaluation approach is covered in the guide on assessing an Etomidate API sample before commercial procurement.
How Etomidate API Is Supplied from India to the USA?
- The buyer submits the required specification, quantity, intended use and document requirements.
- Velcare confirms the available batch or production requirement and issues a quotation.
- The buyer reviews the documentation and evaluates a sample where required.
- The released commercial batch is packaged and dispatched with the applicable shipment records.
- The U.S. importer or customs broker submits the CBP and FDA entry information for the declared use.
The material should remain under the buyer’s incoming-material controls after delivery until its quality unit completes the required document review, sampling, testing and release.
Etomidate API Lead Time
Etomidate API lead time should be quoted against a defined starting point and delivery milestone. A dispatch estimate beginning after purchase-order confirmation is different from a door-to-door estimate ending at the buyer’s facility.
The timeline is determined by:
- Whether the required quantity is available as released stock
- Whether a new batch must be manufactured
- QC testing and QA release status
- Document, packaging and export preparation
- International transportation
- FDA and CBP review
- Final delivery to the named destination
These factors create four distinct timelines:
- Sample dispatch lead time: Time required to allocate, document, package and release the sample for shipment.
- Ex-stock commercial lead time: Time required to allocate an already released batch and complete order-specific documentation and dispatch preparation.
- Made-to-order lead time: Time covering production scheduling, manufacturing, testing, QA release, packaging and export preparation.
- Door-to-door delivery time: The complete period from the agreed starting event until delivery at the named U.S. destination.
Priority courier services commonly publish transit estimates of approximately two to three business days between India and the United States after dispatch. This is a carrier transit estimate, not the total order lead time. It excludes material preparation, QA release and any additional time caused by FDA or CBP review.
Each quotation should therefore identify the batch status, expected release or dispatch date, selected delivery term and activities included in the quoted period. Buyers can review these distinctions in the detailed guide to Etomidate API lead time.
Packaging and Delivery to the United States
Sample and commercial packaging serve different quantities but must protect the same defined material attributes. Velcare confirms the available sample container and commercial pack configuration for each inquiry, including the materials of construction, closure system, net quantity and secondary protection.
The selected configuration should correspond to the packaging specification and stability data for the offered Etomidate batch. Storage and transport conditions must come from supported API information rather than from the labelling of a finished Etomidate injection, which is a different pharmaceutical article.
Delivery may be arranged through express courier for qualifying sample or smaller consignments and through an appropriate air-freight service for larger commercial quantities. The quotation should state:
- The applicable Incoterm and named place
- The party responsible for booking freight
- The importer of record
- Responsibility for U.S. customs and FDA entry
- Freight and insurance treatment
- Expected dispatch and delivery milestones
- Tracking and proof-of-delivery arrangements
Where controlled transportation is required, the parties should also define the acceptable temperature range, monitoring method, excursion-reporting process and responsibility for assessing temperature data after receipt.
Additional considerations for primary containers, protective packaging, labels and transport controls are explained in the article on Etomidate API packaging and storage.
Information to Include in an Etomidate API Inquiry
A complete inquiry allows the proposed batch, documents and delivery schedule to be assessed without repeated clarification. U.S. buyers should provide:
- Required pharmacopoeial grade or controlled specification
- Intended use of the material
- Sample, development or commercial quantity
- Required quality and regulatory documents
- DMF and Letter of Authorization requirements
- Packaging or storage requirements
- Required retest period remaining at delivery
- U.S. delivery location
- Requested delivery date
- Preferred Incoterm
- Estimated annual demand, where relevant
These details separate the immediate order from longer-term regulatory and supply requirements. The guide on requesting an accurate Etomidate API quote explains how to structure this information before approaching a supplier.
Discuss Your Etomidate API Requirement With Velcare
Submit the required Etomidate grade, quantity, intended use, document requirements and U.S. delivery location to Velcare Pharma. Based on these details, Velcare can confirm the proposed batch or production route, sample terms, available pack configuration, regulatory support and milestone-based delivery estimate.
